In solemn circumstances yesterday late afternoon, Lifecare signed a lease for new production facilities and a laboratory in Mainz, Germany. The letter of intent entered into last autumn has thus been formalized with Innovationspark Mainz GmbH & Co KG.
- The lease of production premises ensures modern and effective facilities needed for Lifecares planned scale up of production, with necessary clean room facilities and infrastructure for volume production. At the same time, this contract will give us the desired co-location of our two German subsidiaries, which are now located in Mainz and Reutlingen, says CEO Joacim Holter.
Lifecare's future German department will thus be located at the very entrance to the city of Mainz, in the immediate vicinity of Johannes Gutenberg University and Mainz Technical College. "LAB 1" is being built here, covering around 3,000 square metres. Lifecare AS will rent around 1,000 square meters on the first floor. The company with headquarters in Bergen is now scheduled to move into LAB 1 in the summer of 2025. The duration of the lease is 10 years.
- It has been important for us to ensure continuity in an attractive and central area in Germany with strong traditions in medtech. It has a close location to the academic environment, and this is the first construction stage of a new innovation park that will reinforce the innovative environment that already characterizes the city and the region.
CSO in Lifecare, Prof. Andreas Pfützner points out that the building construction and the facilities at the new innovation park also meet the physical requirements necessary for Lifecare. “We are developing sensor technology at the nano level. For this we need a building optimized to avoid vibration or electrical interference, so that our sensitive production procedures are not affected or disturbed by external conditions. The co-location of the German units will also strengthen cooperation, make future operations more efficient and provide even better utilization of our skilled employees”, says Pfützner.
Lifecare is the first player to have signed an agreement in the new innovation park. On Wednesday 3 May, there will be a ceremonial laying of the foundation stone with the mayor and several ministers present.
__________________________________________________
Lifecare AS is a clinical stage medical sensor company developing technology for sensing and monitoring of various body analytes. Lifecare’s main focus is to bring the next generation of Continuous Glucose Monitoring (“CGM”) systems to market. Lifecare enables osmotic pressure as sensing principle, combined with the ability to manipulate Nano-granular Tunnelling Resistive sensors (“NTR”) on the sensor body for read-out of pressure variations. Lifecare´s sensor technology is referred to as “Sencell” and is suitable for identifying and monitoring the occurrence of a wide range of analytes and molecules in the human body.
__________________________________________________
For further information, please contact:
Joacim Holter, CEO, Lifecare AS, joacim.holter@lifecare.no, +47 40 05 90 40
This information is considered to be inside information pursuant to the EU Market Abuse Regulation and is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act. This stock exchange announcement was published by Joacim Holter, CEO at Lifecare AS, on 27 April 2023 at 8:00 AM CET.